Short Interest in GMO U.S. Value ETF (NYSEARCA:GMOV) Declines By 60.2%

GMO U.S. Value ETF (NYSEARCA:GMOV) was the recipient of a large decrease in short interest in July. As of July 15th, there was short interest totaling 3,493 shares, a decrease of 60.2% from the June 30th total of 8,785 shares. Based on an average daily volume of 34,885 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.1% of the shares of the stock are sold short.

GMO U.S. Value ETF Stock Performance

Shares of NYSEARCA GMOV opened at $31.06 on Monday. The stock has a market cap of $99.39 million, a price-to-earnings ratio of 12.08 and a beta of 0.65. GMO U.S. Value ETF has a 1-year low of $24.79 and a 1-year high of $31.29. The stock’s 50-day moving average is $30.29 and its 200 day moving average is $29.28.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Fifth Third Bancorp bought a new stake in shares of GMO U.S. Value ETF in the 1st quarter worth approximately $84,000. Pathway Financial Advisors LLC bought a new position in shares of GMO U.S. Value ETF during the 2nd quarter valued at $246,000. Kestra Private Wealth Services LLC purchased a new position in GMO U.S. Value ETF in the 1st quarter worth $333,000. Aspen Investment Management Inc purchased a new position in GMO U.S. Value ETF in the 4th quarter worth $333,000. Finally, RPS Advisory Solutions LLC bought a new stake in GMO U.S. Value ETF in the fourth quarter worth $484,000.

GMO U.S. Value ETF Company Profile

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.